Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Sentynl, Cyprium score FDA nod for 1st med for Menkes disease
The FDA has approved Sentynl and Cyprium's Zycubo as the first therapy in the U.S. for the rare genetic neurodegenerative disorder Menkes disease.
Kevin Dunleavy
Jan 13, 2026 10:45am
Vanda, Agios score holiday season FDA approvals
Jan 2, 2026 11:33am
FDA signs off on Omeros' stem cell transplant drug Yartemlea
Dec 26, 2025 12:46pm
Novo snags FDA nod for oral obesity med with Wegovy in a pill
Dec 22, 2025 6:59pm
Cytokinetics scores its first FDA nod with Myqorzo approval
Dec 22, 2025 12:05pm
GSK scoops up yet another FDA approval, this time in asthma
Dec 17, 2025 8:30am
